Skip to main content
Livermore
Livermore
ZHEN

RAPT Therapeutics, Inc.

RAPTDelisted Mar 3, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001673772

RAPT Therapeutics, Inc. was delisted on Mar 3, 2026; its insiders filed their last Form 4 on Mar 5, 2026; 106 institutions reported holding it in 13F filings for Q4 2025, worth $1.02B in total; no superinvestor held it.

Holders of 5% or more of RAPT

Holders whose latest Schedule 13D or 13G filing reports 5% or more of RAPT Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of RAPT
HolderLatest formStakeChangeFirst filedLatest filingFiling
Medicxi IV LP13G16.90%22.4M sharesNewJan 6, 20251 filingJan 6, 2025SEC
TCG Crossover GP II, LLC13G9.99%13.2M sharesNewJan 3, 20251 filingJan 3, 2025SEC
Redmile Group, LLC13G/A9.90%13.9M shares–Feb 14, 20251 filingFeb 14, 2025SEC
Redmile Group, LLC13G/A9.90%1.77M shares–Aug 14, 20251 filingAug 14, 2025SEC
Deep Track Capital, LP13G9.87%14.1M sharesNewDec 23, 20241 filingDec 23, 2024SEC
Foresite Capital Fund VI LP13G9.30%12.5M sharesNewDec 30, 20241 filingDec 30, 2024SEC
ForGrowth III PA B.V.13G7.40%1.83M sharesNewOct 29, 20251 filingOct 29, 2025SEC
OrbiMed Advisors LLC13G/A6.60%1.09M shares−3.30 ppfrom 9.90%Feb 14, 20252 filingsNov 14, 2025SEC
Vanguard Group Inc13G6.27%8.28M shares+4.05 ppfrom 2.22%Feb 7, 20253 filingsApr 30, 2025SEC
RTW Investments, LP13G/A5.90%1.64M shares−3.00 ppfrom 8.90%May 15, 20252 filingsFeb 17, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

23 Schedule 13D and 13G filings on RAPT Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on RAPT
Filed (ET)FilerFormStakeChangeEvent dateFiling
Feb 17, 20268:45 AM ETRTW Investments, LPand 1 other13G/A5.90%1.64M shares−3.00 ppfrom 8.90%Dec 31, 2025SEC
Nov 14, 20256:18 PM ETOrbiMed Advisors LLC13G/A6.60%1.09M shares−3.30 ppfrom 9.90%Sep 30, 2025SEC
Nov 14, 20254:32 PM ETNantahala Capital Management, LLCand 2 others13G/A3.77%623.3K shares−1.98 ppfrom 5.75%Below 5%Sep 30, 2025SEC
Nov 14, 20254:21 PM ETBiotechnology Value Fund L Pand 9 others13G/A0.00%0 shares−8.70 ppfrom 8.70%Below 5%Sep 30, 2025SEC
Oct 30, 20253:50 PM ETVanguard Group Inc13G/A4.20%696.2K shares–Below 5%Sep 30, 2025SEC
Oct 29, 20257:51 PM ETForGrowth III PA B.V.and 2 others13G7.40%1.83M sharesNewOct 23, 2025SEC
Aug 14, 20254:34 PM ETNantahala Capital Management, LLCand 2 others13G5.75%951.6K sharesNewJun 30, 2025SEC
Aug 14, 20254:18 PM ETRedmile Group, LLCand 2 others13G/A9.90%1.77M shares–Jun 30, 2025SEC
May 15, 20258:00 AM ETRTW Investments, LPand 1 other13G8.90%11.8M sharesNewMar 31, 2025SEC
Apr 30, 202511:11 AM ETVanguard Group Inc13G6.27%8.28M shares+4.05 ppfrom 2.22%Mar 31, 2025SEC
Apr 25, 20256:35 PM ETBlackRock, Inc.13G/A1.70%2.31M shares–Below 5%Mar 31, 2025SEC
Feb 14, 20258:02 PM ETRedmile Group, LLCand 2 others13G/A9.90%13.9M shares–Dec 31, 2024SEC
Feb 14, 20254:32 PM ETOrbiMed Advisors LLC13G9.90%13.1M sharesNewDec 31, 2024SEC
Feb 14, 20254:15 PM ETPerceptive Advisors LLCand 2 others13G/A4.50%5.88M shares–Below 5%Dec 31, 2024SEC
Feb 7, 20255:31 PM ETVanguard Group Inc13G/A2.22%2.93M shares0.00 ppfrom 2.22%Below 5%Jan 31, 2025SEC
Feb 7, 20255:31 PM ETVanguard Group Inc13G/A2.22%2.93M shares–Below 5%Jan 31, 2025SEC
Feb 7, 202510:23 AM ETFMR LLCand 1 other13G/A0.40%480.5K shares–Below 5%Jan 31, 2025SEC
Jan 6, 20256:38 PM ETBiotechnology Value Fund L Pand 9 others13G8.70%11.8M sharesNewDec 27, 2024SEC
Jan 6, 20259:22 AM ETMedicxi IV LPand 3 others13G16.90%22.4M sharesNewDec 27, 2024SEC
Jan 3, 20254:08 PM ETTCG Crossover GP II, LLCand 2 others13G9.99%13.2M sharesNewDec 27, 2024SEC
Dec 30, 20243:32 PM ETForesite Capital Fund VI LPand 2 others13G9.30%12.5M sharesNewDec 23, 2024SEC
Dec 23, 20248:20 PM ETColumn Group II, LPand 12 others13D/A4.90%1.60M shares–Below 5%Dec 23, 2024SEC
Dec 23, 20244:42 PM ETDeep Track Capital, LPand 2 others13G9.87%14.1M sharesNewDec 23, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell RAPT Therapeutics, Inc. shares.

No Form 144 notices for RAPT Therapeutics, Inc. are on file.